Crystallisation within transdermal rotigotine patch: is there cause for concern?
Chaudhuri
K Ray
KR
D000279:Administration, Cutaneous; D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000737:chemistry* / Q000633:toxicity; D003460:Crystallization; D006801:Humans; D008958:Models, Molecular; D008968:Molecular Conformation; D013764:Tetrahydronaphthalenes / Q000008:administration & dosage* / Q000737:chemistry* / Q000633:toxicity; D013876:Thiophenes / Q000008:administration & dosage* / Q000737:chemistry* / Q000633:toxicity
D000978:Antiparkinson Agents; D013764:Tetrahydronaphthalenes; D013876:Thiophenes; C047508:rotigotine